A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Cynthia McLaughlin
| Share Statistics | EVGN | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $5.8 | $255.7 | 4% |
|
| Shares Out (Mil) | 12.2 | 54.2 | 23% |
|
| Institutional Ownership | 39.8% | 93.1% | 17% |
|
| Float (Mil) | 14.5 | 41.4 | 24% |
|
| Beta | 0.70 | 0.95 | 41% |
|
| Avg Daily Volume (000s) | 2,803 | 706 | 85% |
|
| Price Change (52-week) |
(64.0%) | 50.7% | 12% |
|
| Growth | EVGN | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 31.3% | 13.2% | 90% |
|
| Net Income (5yr) | 18.3% | (10.1%) | 70% |
|
| EPS (5yr) | 33.5% | 15.8% | 84 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.7%) | (15.6%) | 47% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($0.270) | ($1.700) | ($0.800) | |
| Month Ago EPS | ($0.270) | ($1.700) | ($0.800) | |
| # Rev Up | na | 1 | 1 | |
| # Rev Down | na | 0 | 0 | |
| Three Months Ago EPS | ($0.270) | ($1.700) | ($0.800) | |
| Year/Year Chg | 162.1% | (5.5%) | (69.4%) | |
| Financials | EVGN | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2 | $37 | 3% |
|
| Net Income (TTM) (Mil) | ($9) | ($44) | 30% |
|
| EPS (TTM) | ($0.901) | ($1.600) | 22% |
|
| Operating Cash Flow (TTM) (Mil) | ($11) | ($32) | 19% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $1 | $4 | 18% |
|
| Enterprise Value (Q1) (Mil) | $8 | $174 | 7% |
|
| Valuation | EVGN | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.50 | na |
|
| P/E | na | 18.6 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | EVGN | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (67.6%) | 68.8% | 2% |
|
| Net Margin | (547.6%) | (72.5%) | 1% |
|
| ROA | (33.4%) | (47.6%) | 16% |
|
| ROE | na | (54.9%) | na |
|
| Liabilities to Assets | 57.1% | 29.3% | 50% |
|
| F-Score | 2 | 3 | na |
|
Evogene Ltd. did not pass any screens on 9/29/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
